Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Endoxifen

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Atossa & Quantum Leap Healthcare Provide Enrollment Update for (Z)-Endoxifen
    Atossa & Quantum Leap Healthcare Provide Enrollment Update for (Z)-Endoxifen

    28 Jun 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/atossa-therapeutics-and-quantum-leap-healthcare-provide-enrollment-update-for-z-endoxifen-arm-of-ongoing-i-spy-2-clinical-trial-301865328.html

    PR NEWSWIRE
    28 Jun 2023
    Share Share
    Atossa Therapeutics Updated Endoxifen Safe and Well Tolerated
    Atossa Therapeutics Updated Endoxifen Safe and Well Tolerated

    09 Jun 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/06/09/2244416/0/en/Atossa-Therapeutics-Announces-Final-Data-from-Phase-2-Endoxifen-Breast-Cancer-Study-Primary-Endpoint-Met-65-1-Reduction-in-Biomarker-Ki-67-Secondary-Endpoint-Met-Endoxifen-Safe-and.html

    GLOBENEWSWIRE
    09 Jun 2021
    Share Share
    Atossa Announces Findings from FDA-Approved Expanded Access Treatment Endoxifen
    Atossa Announces Findings from FDA-Approved Expanded Access Treatment Endoxifen

    30 Jul 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/07/30/2070456/0/en/Atossa-Therapeutics-Announces-Findings-from-FDA-Approved-Expanded-Access-Treatment-with-Endoxifen.html

    GLOBENEWSWIRE
    30 Jul 2020
    Share Share